Virtual Screening and Biochemical Evaluation of Mitogen-activated Protein Kinase Phosphatase 4 Inhibitors 


Vol. 33,  No. 11, pp. 3772-3776, Nov.  2012
10.5012/bkcs.2012.33.11.3772


PDF
  Tumbnail

  Abstract

Mitogen-activated protein kinase phosphatase 4 (MKP4) has proved to be a promising target for the development of therapeutics for the treatment of diabetes and the other metabolic diseases. Here, we report an example for a successful application of the structure-based virtual screening to identify three novel inhibitors of MKP4. These inhibitors have desirable physicochemical properties as a drug candidate and reveal a moderate potency with IC50 values ranging from 4.9 to 32.3 μM. Therefore, they deserve consideration for further development by structure-activity relationship studies to optimize the inhibitory and antidiabetic activities. Structural features relevant to the stabilization of the newly identified inhibitors in the active site of MKP4 are discussed in detail.

  Statistics
Cumulative Counts from November, 2022
Multiple requests among the same browser session are counted as one view. If you mouse over a chart, the values of data points will be shown.


  Cite this article

[IEEE Style]

H. Park, J. Jeon, S. E. Ryu, "Virtual Screening and Biochemical Evaluation of Mitogen-activated Protein Kinase Phosphatase 4 Inhibitors," Bulletin of the Korean Chemical Society, vol. 33, no. 11, pp. 3772-3776, 2012. DOI: 10.5012/bkcs.2012.33.11.3772.

[ACM Style]

Hwangseo Park, Jeong-Yi Jeon, and Seong Eon Ryu. 2012. Virtual Screening and Biochemical Evaluation of Mitogen-activated Protein Kinase Phosphatase 4 Inhibitors. Bulletin of the Korean Chemical Society, 33, 11, (2012), 3772-3776. DOI: 10.5012/bkcs.2012.33.11.3772.

Search
(IN TITLE, AUTHOR, ABSTRACT,KEYWORDS)

Advanced Search ▼

POPULAR KEYWORDS
(TOP 10 KEYWORDS)

Recent Publications
(LAST 3 YEARS)

ISSN(Print) 0253-2964
ISSN(Online) 1229-5949